Ryvu Therapeutics SA(GB:0RKT)
zł 30.250.00 (0.00%)
GB:0RKT
Ryvu Therapeutics SA financials statements
zł 30.25
At close:0.00 (0.00%)
Ryvu Therapeutics SA (0RKT) Income Statement
0 Followers
Ryvu Therapeutics SA Income Statement
Last quarter (Q2 2026), Ryvu Therapeutics SA's total revenue was zł11.99M, a decrease of 3.35% from the same quarter last year. In Q2, Ryvu Therapeutics SA's net income was zł-13.06M. See Ryvu Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| zł 62.25M | zł 77.97M | zł 46.86M | zł 38.80M | zł 11.19M | |
| zł -117.03M | zł 58.39M | zł 29.31M | zł 21.40M | zł -2.54M | |
| zł 5.12M | zł 180.49M | zł 130.25M | zł 93.07M | zł 75.98M | |
| Depreciation and Amortization | zł 9.44M | zł 10.49M | zł 10.97M | zł 12.90M | zł 12.56M |
| zł -112.71M | zł -96.83M | zł -81.04M | zł -65.21M | zł -65.96M | |
| zł -122.15M | zł -122.10M | zł -100.95M | zł -78.42M | zł -103.78M | |
| zł 21.01M | zł 10.96M | zł 8.84M | zł -773.00K | zł -363.00K | |
| zł -101.14M | zł -111.14M | zł -92.11M | zł -79.19M | zł -78.96M | |
| zł -101.23M | zł -111.44M | zł -92.11M | zł -83.78M | zł -79.08M | |
| Per Share Metrics | |||||
| Basic EPS | zł -4.38 | zł -4.82 | zł -4.02 | zł -4.57 | zł -4.31 |
| Diluted EPS | zł -4.38 | zł -4.82 | zł -4.02 | zł -4.57 | zł -4.31 |
| Weighted Average Shares Outstanding | 23.12M | 23.12M | 22.90M | 18.33M | 18.36M |
| Weighted Average Shares Outstanding (Diluted) | 23.12M | 23.12M | 22.90M | 18.33M | 18.36M |
Currency in PLN

